Literature DB >> 27227341

Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer Patients.

Leanne K Jackson1, Sheila H Ridner2, Jie Deng2, Carmin Bartow3, Kyle Mannion4, Ken Niermann5, Jill Gilbert1, Mary S Dietrich6, Anthony J Cmelak5, Barbara A Murphy1.   

Abstract

BACKGROUND: Tumor/treatment-related internal lymphedema (IL) and/or external lymphedema (EL) are associated with functional deficits and increased symptom burden in head and neck cancer patients (HNCP). Previously, we noted association between EL/IL and patient-reported dysphagia using the Vanderbilt Head and Neck Symptom Survey (VHNSS) version 1.0.
OBJECTIVE: To determine the relationship between IL/EL and subjective and objective measures of swallowing function.
METHODS: Eighty-one HNCP completed: (1) VHNSS version 2.0, including 13 swallowing/nutrition-related questions grouped into three clusters: swallow solids (ss), swallow liquids (sl), and nutrition(nt); (2) physical assessment of EL using Foldi scale; (3) endoscopic assessment of IL using Patterson scale (n = 56); and (4) modified barium swallow study rated by dysphagia outcome and severity scale (DOSS) and in conjunction with a swallow evaluation by National Outcomes Measurement System (NOMS). Examinations were performed at varied time points to assess lymphedema spectrum, from baseline (n = 15, 18.1%) to 18 months post-therapy (n = 20, 24.1%).
RESULTS: VHNSS swallow/nutrition items scores correlated with NOMS/DOSS ratings (p < 0.001). Highest correlation was with NOMS: ss (-0.73); sl (-0.61); nt (-0.56). VHNSS swallow/nutrition scores correlated with maximum grade of swelling for any single structure on Patterson scale: ss (0.43; p = 0.001); sl (0.38; p = 0.004); nt (0.41; p = 0.002). IL of aryepiglottic/pharyngoepiglottic folds, epiglottis, and pyriform sinus were most strongly correlated with VHNSS and NOMS ratings. NOMS/DOSS ratings correlated with EL (> = -0.34; p < 0.01). No meaningful correlations exist between VHNSS swallow/nutrition items and EL (< ± 0.15, p > 0.20).
CONCLUSIONS: IL correlated with subjective and objective measures of swallow dysfunction. Longitudinal analysis of trajectory and impact of IL/EL on dysphagia is ongoing.

Entities:  

Mesh:

Year:  2016        PMID: 27227341      PMCID: PMC5011629          DOI: 10.1089/jpm.2016.0018

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  17 in total

Review 1.  Lymphedema in patients with head and neck cancer.

Authors:  Jie Deng; Sheila H Ridner; Barbara A Murphy
Journal:  Oncol Nurs Forum       Date:  2011-01       Impact factor: 2.172

2.  Lymphoedema following treatment for head and neck cancer: impact on patients, and beliefs of health professionals.

Authors:  A C McGarvey; P G Osmotherly; G R Hoffman; P E Chiarelli
Journal:  Eur J Cancer Care (Engl)       Date:  2013-10-10       Impact factor: 2.520

3.  The mechanism of the larynx. II. The epiglottis and closure of the larynx.

Authors:  G M Ardran; F H Kemp
Journal:  Br J Radiol       Date:  1967-05       Impact factor: 3.039

4.  The Dysphagia Outcome and Severity Scale.

Authors:  K H O'Neil; M Purdy; J Falk; L Gallo
Journal:  Dysphagia       Date:  1999       Impact factor: 3.438

5.  Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues.

Authors:  Nam P Nguyen; Sabah Sallah; Ulf Karlsson; John E Antoine
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

6.  Patients' awareness of symptoms of dysphagia.

Authors:  Faerella Boczko
Journal:  J Am Med Dir Assoc       Date:  2006-11       Impact factor: 4.669

7.  Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy.

Authors:  C L Lazarus; J A Logemann; B R Pauloski; L A Colangelo; P J Kahrilas; B B Mittal; M Pierce
Journal:  Laryngoscope       Date:  1996-09       Impact factor: 3.325

8.  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Authors:  Marshall R Posner; Diane M Hershock; Cesar R Blajman; Elizabeth Mickiewicz; Eric Winquist; Vera Gorbounova; Sergei Tjulandin; Dong M Shin; Kevin Cullen; Thomas J Ervin; Barbara A Murphy; Luis E Raez; Roger B Cohen; Monica Spaulding; Roy B Tishler; Berta Roth; Rosana del Carmen Viroglio; Varagur Venkatesan; Ilya Romanov; Sanjiv Agarwala; K William Harter; Matthew Dugan; Anthony Cmelak; Arnold M Markoe; Paul W Read; Lynn Steinbrenner; A Dimitrios Colevas; Charles M Norris; Robert I Haddad
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

9.  Swallow function and perception of dysphagia in patients with head and neck cancer.

Authors:  Barbara Roa Pauloski; Alfred W Rademaker; Jerilyn A Logemann; Cathy L Lazarus; Lisa Newman; Annette Hamner; Ellen MacCracken; Joy Gaziano; Linda Stachowiak
Journal:  Head Neck       Date:  2002-06       Impact factor: 3.147

10.  Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life.

Authors:  Jie Deng; Barbara A Murphy; Mary S Dietrich; Nancy Wells; Kenneth A Wallston; Robert J Sinard; Anthony J Cmelak; Jill Gilbert; Sheila H Ridner
Journal:  Head Neck       Date:  2012-07-12       Impact factor: 3.147

View more
  7 in total

1.  Patient experience of head and neck lymphedema therapy: a qualitative study.

Authors:  Jie Deng; Robert J Sinard; Barbara Murphy
Journal:  Support Care Cancer       Date:  2018-08-30       Impact factor: 3.603

2.  Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.

Authors:  Jie Deng; Mary S Dietrich; Kenneth J Niermann; Robert J Sinard; Anthony J Cmelak; Sheila H Ridner; Jill Gilbert; Barbara A Murphy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-10-14       Impact factor: 8.013

3.  Analysis of pharyngeal edema post-chemoradiation for head and neck cancer: Impact on swallow function.

Authors:  Maria C Turcotte; Erica G Herzberg; Matina Balou; Sonja M Molfenter
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-09-24

4.  A Mobile Patient-Facing App for Tracking Patient-Reported Outcomes in Head and Neck Cancer Survivors: Single-Arm Feasibility Study.

Authors:  Sewit Teckie; Jeffrey Solomon; Karthik Kadapa; Keisy Sanchez; David Orner; Dennis Kraus; Dev P Kamdar; Lucio Pereira; Douglas Frank; Michael Diefenbach
Journal:  JMIR Form Res       Date:  2021-03-19

5.  Quantitative clinical outcomes of therapy for head and neck lymphedema.

Authors:  Kaleigh N Doke; Laine Bowman; Yelizaveta Shnayder; Xinglei Shen; Mindi TenNapel; Sufi Mary Thomas; Prakash Neupane; Hung-Wen Yeh; Chris E Lominska
Journal:  Adv Radiat Oncol       Date:  2018-04-27

6.  Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity.

Authors:  M Sean Peach; Daniel M Trifiletti; Carolyn Vachani; Karen Arnold-Korzeniowski; Christina Bach; Margaret Hampshire; James M Metz; Christine E Hill-Kayser
Journal:  Patient Relat Outcome Meas       Date:  2018-07-27

7.  Translation and adaptation of the Radiotherapy Edema Rating Scale to Brazilian Portuguese.

Authors:  Débora Dos Santos Queija; Lica Arakawa-Sugueno; Bruna Mello Chamma; Marco Aurélio Vamondes Kulcsar; Rogério Aparecido Dedivitis
Journal:  Braz J Otorhinolaryngol       Date:  2017-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.